Design of a randomized controlled trial to Link Infectious and Narcology Care (LINC-II) in St. Petersburg, Russia.
Natalia GnatienkoDmitry LioznovAnita RajElena BlokhinaSydney RosenDebbie M ChengKarsten LunzeSally BendiksVe TruongNatalia BusharaOlga ToussovaEmily QuinnEvgeny KrupitskyJeffrey H SametPublished in: Addiction science & clinical practice (2020)
This RCT will assess the LINC-II intervention in an urban Russian setting. If effective, it will offer a new approach for increasing the uptake of both HIV and opioid use disorder treatment and coordination of these modalities in standard Eastern European clinical settings. Trial registration This study was registered with ClinicalTrials.gov through the National Institutes of Health, NCT03290391. Registered 19 September 2017, https://clinicaltrials.gov/ct2/show/NCT03290391.
Keyphrases
- long non coding rna
- healthcare
- quality improvement
- long noncoding rna
- cell proliferation
- antiretroviral therapy
- hiv infected
- randomized controlled trial
- public health
- hiv positive
- computed tomography
- human immunodeficiency virus
- clinical trial
- palliative care
- mental health
- study protocol
- hiv testing
- hepatitis c virus
- magnetic resonance imaging
- men who have sex with men
- phase iii
- magnetic resonance
- phase ii
- positron emission tomography
- chronic pain
- social media
- combination therapy
- pet ct
- health promotion